Advances in the management of liver and biliary tumors

被引：2
|
作者：
Jarnagin, William R. [1 ]
D'Angelica, Michael, I [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Hepatopancreatobiliary Serv, 1275 York Ave, New York, NY 10065 USA
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2022年 / 126卷 / 05期
关键词：
biliary cancer; cholangiocarcinoma; gallbladder cancer; hepatic colorectal metastasis; hepatocellular carcinoma; liver cancer; HEPATIC ARTERIAL INFUSION; METASTATIC COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; BLOOD-LOSS; RESECTION; CHEMOTHERAPY; SURVIVAL; TRANSFUSION; MORTALITY; OPERATION;
D O I：
10.1002/jso.27039
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Over the past 50 years, the management of liver and biliary tumors has evolved significantly. Initially considered highly morbid and lethal, resection is now the treatment of choice for a significant proportion of patients with malignant and benign hepatobiliary disease. Improved operative/anesthetic techniques, use of parenchymal-sparing approaches, better patient selection for surgery, effective liver-directed therapies, and new insights into tumor biology are significant contributors to our transformed approach to hepatobiliary neoplasms.
引用
收藏
页码：872 / 875
页数：4
相关论文
共 50 条
12345